| Literature DB >> 25379041 |
Gurler Akpinar1, Murat Kasap2, Ayca Aksoy3, Gokhan Duruksu3, Gulcin Gacar3, Erdal Karaoz4.
Abstract
The level of heterogeneity among the isolated stem cells makes them less valuable for clinical use. The purpose of this study was to understand the level of heterogeneity among human dental pulp derived mesenchymal stem cells by using basic cell biology and proteomic approaches. The cells were isolated from a natal (NDPSCs), an exfoliated deciduous (stem cells from human exfoliated deciduous (SHED)), and an impacted third molar (DPSCs) tooth of three different donors. All three stem cells displayed similar features related to morphology, proliferation rates, expression of various cell surface markers, and differentiation potentials into adipocytes, osteocytes, and chondrocytes. Furthermore, using 2DE approach coupled with MALDI-TOF/TOF, we have generated a common 2DE profile for all three stem cells. We found that 62.3 ± 7% of the protein spots were conserved among the three mesenchymal stem cell lines. Sixty-one of these conserved spots were identified by MALDI-TOF/TOF analysis. Classification of the identified proteins based on biological function revealed that structurally important proteins and proteins that are involved in protein folding machinery are predominantly expressed by all three stem cell lines. Some of these proteins may hold importance in understanding specific properties of human dental pulp derived mesenchymal stem cells.Entities:
Year: 2014 PMID: 25379041 PMCID: PMC4212660 DOI: 10.1155/2014/457059
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Immunophenotypic characteristics of NDPSCs, SHED, and hDDP-MSCs. The figures in the table are percentages of CD positive cells.
| Markers | NDPSCs | SHED | DPSCs |
|---|---|---|---|
| CD13 | 90.87 ± 5.24 | 89.73 ± 6.76 | 94.34 ± 8.42 |
| CD14 | 0.78 ± 0.62 | 0.78 ± 0.86 | 0.16 ± 0.07 |
| CD29 | 99.43 ± 0.28 | 99.88 ± 0.08 | 99.44 ± 0.37 |
| CD34 | 0.93 ± 0.62 | 0.24 ± 0.08 | 0.29 ± 0.24 |
| CD44 | 98.62 ± 1.33 | 99.80 ± 0.12 | 99.77 ± 0.26 |
| CD45 | 0.65 ± 0.42 | 0.28 ± 0.09 | 0.12 ± 0.05 |
| CD73 | 99.69 ± 0.36 | 99.76 ± 0.36 | 99.56 ± 0.14 |
| CD90 | 97.62 ± 3.17 | 99.73 ± 0.28 | 99.49 ± 0.32 |
| CD106 | 1.04 ± 0.70 | 1.18 ± 0.39 | 0.14 ± 0.02 |
| CD117 | 5.68 ± 0.24 | 1.74 ± 1.72 | 0.94 ± 0.85 |
| CD146 | 81.38 ± 7.33 | 57.91 ± 0.76 | 54.44 ± 23.89 |
| CD166 | 99.15 ± 0.97 | 99.51 ± 0.60 | 98.59 ± 0.97 |
| HLA-ABC | 94.88 ± 5.25 | 66.89 ± 6.36 | 83.15 ± 5.65 |
| HLA-DR | 0.56 ± 0.39 | 0.12 ± 0.02 | 0.17 ± 0.05 |
Figure 1Illustration of MSC morphologies and relevant growth kinetics. (a) Morphology of NDPSCs, SHED, and DPSCs. The cells were at passage three. Images were taken with an inverted microscope (40X). (b) Growth curves for NDPSCs, SHED, and DPSCs over a period of 25 days. The cells were cultured in 96-well plates in triplicate and their growth rates were followed by WST-1 assay, which measures cell viability. DPSCs displayed relatively lower growth rate than SHED and NDPSCs.
Figure 2Cell cycle analysis of NDPSCs, SHED, and DPSCs. Each sample (10,000 cells) was counted in triplicate by a flow cytometer. The values are expressed as percentage mean ± standard deviation.
Figure 3Telomerase activities of NDPSCs, SHED, and DPSCs. The activities were measured by conventional telomeric repeat amplification protocol (TRAP) and relative telomerase activities (RTA) were calculated with respect to the control template equivalent to 0.001 mol/μL DNA.
Figure 4In vitro differentiation potential of NDPSCs, SHED, and DPSCs. ((a1), (b1), and (c1)). Adipogenic differentiation is visually marked by accumulation of neutral lipid vacuoles in cultures (Oil Red staining). Actin ((a1) and (b1)) and vimentin (c1) expression were shown in green and nuclei in blue with DAPI. ((a2), (b2), and (c2)) Osteogenic differentiation was indicated by the formation of calcified nodule with Alizarin Red S staining. ((a3), (b3), and (c3)) The analyzed sections were positive for Safranin O staining after chondrogenic differentiation.
Figure 5Comparative proteome analysis of NDPSCs, SHED, and DPSCs. (a) Undifferentiated MSCs were subjected to protein isolation and loaded onto pH 5 to pH 8 IPG strips for the first dimension and precast SDS-PAGE gels for the second dimension separation and stained with Colloidal Coomassie Blue for 24 hr after 24 hours of fixation. The gels are representative of three gels from each MSC type. (b) Master gel image was created by PDQuest Advance software to determine the number of spots that matched every member (183 spots). The numbers represent SSP numbers assigned to each spot by the software. These spots were cut from the gels and were subjected to MALDI-TOF/TOF analysis. Protein identification was performed by peptide mass finger printing by MASCOT (c) Pie charts to illustrate proteome conservation ratios among hNDP, SHED, and hDP-MSCs. Changes in spot intensities among 183 matching spots were compared. Spots that were up- or downregulated more than 2-fold were considered to be subjected to regulation.
Protein spots that were identified by MALDI-TOF/TOF (MS/MS) analysis.
| SSP | Swiss-Prot accession | Best protein description | Sequence coverage/matches | MASCOT probability/expect (p) | Theoretical | Experimental p |
|---|---|---|---|---|---|---|
| 3001 | P 09382 | Galectin-1 | 40%/9 fragment | 236/5.10 | 14706 | 5.34 |
| 3005 | P 06703 | Protein S100-A6 | 24%/7 fragment | 124/8.10 | 10173 | 5.33 |
| 4003 | P 62988 | Ubiquitin | 31%/5 fragment | 151/1.60 | 8560 | 6.56 |
| 5002 | O 75368 | SH3 domain-binding glutamic acid-rich-like protein | 22%/5 fragment | 181/1.60 | 12766 | 5.22 |
| 5001 | Q 14019 | Coactosin-like protein | 28%/7 fragment | 93/1.00 | 15935 | 5.54 |
| 4001 | O 75347 | Tubulin-specific chaperone A | 48%/10 fragment | 295/6.40 | 12847 | 5.25 |
| 3003 | Q 9NQ39 | Putative 40S ribosomal protein S10-like | 20%/7 fragment | 22/1.10 | 20108 | 10.13 |
| 3002 | P 63241 | Eukaryotic translation initiation factor 5A-1 | 15%/5 fragment | 177/4.00 | 16821 | 5.08 |
| 3004 | O 95881 | Thioredoxin domain-containing protein 12 | 12%/4 fragment | 47/0.41 | 19194 | 5.24 |
| 3101 | P 52815 | 39S ribosomal protein L12, mitochondrial | 15%/4 fragment | 164/8.10 | 21335 | 9.04 |
| 4101 | O 75947 | ATP synthase subunit d, mitochondrial | 32%/8 fragment | 322/1.30 | 18480 | 5.21 |
| 4102 | P 09936 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | 22%/8 fragment | 212/1.30 | 24808 | 5.33 |
| 4002 | P 07858 | Cathepsin B | 5%/1 fragment | 107/4.00 | 37797 | 5.88 |
| 3201 | P 43487 | Ran-specific GTPase-activating protein | 28%/10 fragment | 167/4.00 | 23296 | 5.19 |
| 6102 | P 32119 | Peroxiredoxin-2 | 34%/15 fragment | 536/5.10 | 21878 | 5.66 |
| 6104 | P 30085 | UMP-CMP kinase | 13%/5 fragment | 140/2.00 | 22208 | 5.44 |
| 6202∗ | P 04792 | Heat shock protein beta-1 | 33%/12 fragment | 321/1.60 | 22768 | 5.98 |
| 7101 | P 00441 | Superoxide dismutase [Cu-Zn] | 9%/2 fragment | 101/1.60 | 15926 | 5.7 |
| 6001 | O 15511 | Actin related protein 2/3 complex subunit 5 | 12%/3 fragment | 78/0.00035 | 16310 | 5.47 |
| 7001 | Q 12912 | Lymphoid-restricted membrane protein | 1%/2 fragment | 25/67 | 62069 | 5.62 |
| 7204 | P 07339 | Cathepsin D | 20%/17 fragment | 503/1.00 | 44524 | 6.1 |
| 7205 | Q 99436 | Proteasome subunit beta type 7 | 14%/9 fragment | 150/2.00 | 29946 | 7.57 |
| 7102 | P 09211 | Glutathione S-transferase P | 16%/5 fragment | 215/6.4 | 23341 | 5.43 |
| 4201A∗ | P 07858 | Cathepsin B | 28%/14 fragment | 574/8.10 | 37797 | 5.88 |
| 4201B | O 00299 | Chloride intracellular channel protein 1 | 10%/6 fragment | 130/2.00 | 26906 | 5.09 |
| 8101 | P 04792 | Heat shock protein beta-1 | 45%/22 fragment | 707/4.00 | 22768 | 5.98 |
| 8201 | P 30048 | Thioredoxin-dependent peroxide reductase, mitochondrial | 23%/10 fragment | 346/5.10 | 27675 | 7.67 |
| 9102 | O 95571 | Protein ETHE1, mitochondrial | 35%/12 fragment | 439/2.60 | 27855 | 6.35 |
| 9101 | Q 99497 | Protein DJ-1 | 33%/10 fragment | 239/2.60 | 19878 | 6.33 |
| 8202 | P 30084 | Enoyl-CoA hydratase, mitochondrial | 25%/10 fragment | 183/1.00 | 31367 | 8.34 |
| 9202∗ | P 60174 | Triosephosphate isomerase | 64%/24 fragment | 872/1.30 | 26653 | 6.45 |
| 9203∗ | P 07339 | Cathepsin D | 16%/14 fragment | 233/1.00 | 44524 | 6.1 |
| 8002 | P 31949 | Protein S100-A11 | 56%/10 fragment | 312/1.30 | 11733 | 6.56 |
| 9003 | P 49773 | Histidine triad nucleotide-binding protein 1 | 16%/4 fragment | 139/2.60 | 13793 | 6.43 |
| 9002 | Q 969H8 | UPF0556 protein C19orf10 | 30%/12 fragment | 437/4.00 | 18783 | 6.2 |
| 9201 | P 60174 | Triosephosphate isomerase | 71%/28 fragment | 994/8.10 | 26653 | 6.45 |
| 9215 | P 18669 | Phosphoglycerate mutase 1 | 41%/13 fragment | 627/4.00 | 28786 | 6.67 |
| 9213 | O 00560 | Syntenin-1 | 24%/13 fragment | 257/4.00 | 32424 | 7.05 |
| 9212 | Q 99439 | Calponin-2 | 11%/9 fragment | 79/0.00027 | 33675 | 6.95 |
| 9211 | O 14979 | Heterogeneous nuclear ribonucleoprotein D-like | 15%/13 fragment | 361/1.60 | 46409 | 9.59 |
| 9209 | P 04083 | Annexin A1 | 15%/9 fragment | 233/1.00 | 38690 | 6.57 |
| 9221 | Q 99729 | Heterogeneous nuclear ribonucleoprotein A/B | 18%/8 fragment | 145/6.40 | 36202 | 8.22 |
| 9308 | Q 14103 | Heterogeneous nuclear ribonucleoprotein D0 | 20%/11 fragment | 301/1.60 | 38410 | 7.62 |
| 9305 | P 60709 | Actin, cytoplasmic 1 | 24%/14 fragment | 360/2.00 | 41710 | 5.29 |
| 9402 | P 06733 | Alpha-enolase | 24%/19 fragment | 494/8.10 | 47139 | 7.01 |
| 9401 | P 13929 | Beta-enolase | 14%/8 fragment | 165/6.40 | 46902 | 7.59 |
| 9401 | P 09104 | Gamma-enolase | 11%/6 fragment | 159/2.60 | 47239 | 4.91 |
| 9903 | Q 8WXF1 | Paraspeckle component 1 | 17%/14 fragment | 236/5.10 | 58706 | 6.26 |
| 9902 | P 04264 | Keratin, type II cytoskeletal 1 | 9%/9 fragment | 416/5.10 | 65999 | 8.15 |
| 9901 | Q 05682 | Caldesmon | 24%/23 fragment | 512/1.30 | 93194 | 5.63 |
| 8901 | Q 15942 | Zyxin | 21%/19 fragment | 287/4.00 | 61238 | 6.22 |
| 8502 | P 17661 | Desmin | 14%/10 fragment | 137/4.00 | 53503 | 5.21 |
| 7401 | P 31943 | Heterogeneous nuclear ribonucleoprotein H | 49%/29 fragment | 966/5.10 | 49198 | 5.89 |
| 9603 | P 08670 | Vimentin | 75%/57 fragment | 1290/2.00 | 53619 | 5.06 |
| 8302 | O 14773 | Tripeptidyl-peptidase 1 | 4%/4 fragment | 189/2.60 | 61210 | 6.01 |
| 8301 | P 40121 | Macrophage-capping protein | 23%/18 fragment | 465/6.40 | 38494 | 5.88 |
| 5202 | P 52907 | F-actin-capping protein subunit alpha-1 | 44%/11 fragment | 210/2.00 | 32902 | 5.45 |
| 6903 | P 11142 | Heat shock cognate 71 kDa protein | 24%/19 fragment | 472/1.3 | 70854 | 5.37 |
| 5902 | P 10809 | 60 kDa heat shock protein, mitochondrial | 27%/18 fragment | 475/6.4 | 61016 | 5.7 |
| 5604 | Q 16352 | Alpha-internexin | 5%/3 fragment | 72/0.0012 | 55357 | 5.34 |
| 4902∗ | Q 96AY3 | Peptidyl-prolyl | 5%/5 fragment | 73/0.00093 | 64204 | 5.36 |
| 4901 | P 11021 | 78 kDa glucose-regulated protein | 22%/16 fragment | 426/5.1 | 72288 | 5.07 |
| 7003 | P 15531 | Nucleoside diphosphate kinase A | 37%/11 fragment | 348/3.20 | 17138 | 5.83 |
| 9005 | Q 01469 | Fatty acid-binding protein | 27%/5 fragment | 246/5.10 | 15155 | 6.6 |
| 9204 | P 25786 | Proteasome subunit alpha type 1 | 25%/9 fragment | 166/5.1 | 29537 | 6.15 |
| 9206∗ | P 60174 | Triosephosphate isomerase | 30%/8 fragment | 116/5.1 | 26653 | 6.45 |
| 9010 | P 62937 | Peptidyl-prolyl | 17%/5 fragment | 150/2.00 | 18001 | 7.68 |
*Some of the identified proteins appeared as more than one spot on the gels as indicated by the presence of more than one SSP number.
Classification of the proteins that were identified by MALDI-TOF/TOF analysis. The classifications were made based on PANTHER analysis and Swiss-Prot annotations.
| Protein name | Function | Biological process involved |
|---|---|---|
| Apoptosis related | ||
| Galectin | Apoptosis, cell proliferation, and differentiation | Apoptosis |
| Cathepsin B | Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. | Regulation of apoptotic process and proteolysis |
| Cathepsin D | Acid protease active in intracellular protein breakdown | Regulation of apoptotic process and proteolysis |
| Histidine triad nucleotide-binding protein 1 | Hydrolyzes purine nucleotide phosphoramidates | Apoptosis |
|
| ||
| Signal transduction | ||
| SA100A6 | May function as calcium sensor and modulator, contributing to cellular calcium signaling | Signal transduction |
| Protein S100-A11 | Signal transduction | |
| Annexin A1 | Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis | Cell surface receptor signaling pathway |
|
| ||
| Protein biosynthesis and degradation | ||
| Ubiquitin | Behaves as a molecular tag for degradation of proteins | Ubiquitination |
| Putative 40S ribosomal protein S10-like | Ribonucleoprotein | Protein biosynthesis |
| Eukaryotic translation initiation factor 5A-1 | Ribosome binding | Protein biosynthesis |
| Ubiquitin carboxyl-terminal hydrolase | Processing of ubiquitin precursors and of ubiquitinated proteins | Ubl conjugation pathway |
| 39S ribosomal protein L12, mitochondrial | Ribonucleoprotein | Mitochondrial protein biosynthesis |
| Proteasome subunit alpha type 1 | The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH | Immunity |
| Proteasome subunit beta type 7 | Cleavage of peptide bonds with very broad specificity | Protein degradation |
|
| ||
| Transcription related | ||
| Heterogeneous nuclear ribonucleoprotein A/B | Binds single-stranded RNA. Has a high affinity for G-rich and U-rich regions of hnRNA | Transcription, |
| Heterogeneous nuclear ribonucleoprotein D0 | Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3′-UTR of many protooncogenes and cytokine mRNAs | Transcription, |
| Heterogeneous nuclear ribonucleoprotein H | This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative splicing regulation | Mediates pre-mRNA alternative splicing regulation |
| Heterogeneous nuclear ribonucleoprotein D-like | Acts as a transcriptional regulator. Promotes transcription repression. | Transcription, |
| Paraspeckle component 1 | Regulates, cooperatively with NONO and SFPQ, androgen receptor-mediated gene transcription activity in Sertoli cell line | Transcription, |
|
| ||
| Nucleotide metabolism | ||
| UMP-CMP kinase | Catalyzes the phosphorylation of pyrimidine nucleoside monophosphates at the expense of ATP | Nucleotide metabolism |
| Nucleoside diphosphate kinase A | Major role in the synthesis of nucleoside triphosphates other than ATP | Nucleotide metabolism |
|
| ||
| Redox metabolism related | ||
| Thioredoxin domain-containing protein 12 | Possesses significant protein thiol-disulfide oxidase activity | Oxidoreductase |
| Peroxiredoxin-2 | Involved in redox regulation of the cell. Reduces peroxides with reducing equivalents provided through the thioredoxin system | Hydrogen peroxide catabolic process |
| Superoxide dismutase [Cu-Zn] | Destroys radicals which are normally produced within the cells and which are toxic to biological systems. | Antioxidant, |
| Thioredoxin-dependent peroxide reductase | Peroxidase activity, | Involved in redox regulation of the cell |
| Glutathione S-transferase P | Conjugation of reduced glutathione to a wide number of exogenous and endogenous substrates | Glutathione derivative biosynthetic process |
| Persulfide dioxygenase ETHE1, mitochondrial | Plays ab essential role in hydrogen sulfide catabolism in the mitochondrial matrix | Hydrogen sulfide metabolic process |
|
| ||
| Protein folding/stress | ||
| Tubulin-specific chaperone A | Involves the early step of the tubulin folding pathway. | Chaperone binding |
| UPF0556 protein C19orf10 | Involved in unfolded protein response, cellular protein metabolic process | |
| Protein DJ-1 | Protects cells against oxidative stress and cell death. | Oxidative stress |
| Heat shock protein beta-1 | Involved in stress resistance and actin organization. | Stress response |
| Heat shock cognate 71 kDa protein | Acts as a repressor of transcriptional activation | Stress response |
| 60 kDa heat shock protein, mitochondrial | Implicated in mitochondrial protein import and macromolecular assembly | de novo' protein folding, |
| 78 kDa glucose-regulated protein | Plays a role in facilitating the assembly of multimeric protein complexes inside the endoplasmic reticulum | ER overload response |
| Peptidyl-prolyl | It catalyzes the | PPIases accelerate the folding of proteins |
| Tripeptidyl-peptidase 1 | Lysosomal serine protease with tripeptidyl-peptidase I activity | Involved in unfolded protein response |
|
| ||
| Energy metabolism | ||
| ATP synthase subunit D | ATP synthesis | Energy metabolism |
| Phosphoglycerate mutase 1 | Interconversion of 3- and 2-phosphoglycerate | Glycolysis, gluconeogenesis |
| Alpha-enolase | Role in glycolysis, plays a part in various processes such as growth control, hypoxia tolerance, and allergic responses. | Glycolysis, |
| Beta-enolase | Striated muscle development and regeneration. | Glycolysis |
| Gamma-enolase | Has neurotrophic and neuroprotective properties on a broad spectrum of central nervous system (CNS) neurons | Glycolysis |
| Triosephosphate isomerase | D-Glyceraldehyde 3-phosphate = glycerone phosphate. | Energy metabolism |
|
| ||
| Structural proteins | ||
| Coactosin-like protein | Acts as a chaperone for ALOX5 (5LO), influencing both its stability and activity in leukotrienes synthesis. | Binds to F-actin in a calcium-independent manner |
| Actin related protein 2/3 complex subunit 5 | Component of the Arp2/3 complex which is involved in regulation of actin polymerization | Structural constituent of cytoskeleton |
| Syntenin-1 | An adapter protein, in adherens junctions may function to couple syndecans to cytoskeletal proteins or signaling components | Actin cytoskeleton organization |
| Calponin-2 | Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contra | Actin binding |
| Actin, cytoplasmic 1 | Cell motility | Cell structure formation |
| Keratin, type II cytoskeletal 1 | Regulate the activity of kinases such as PKC and SRC via binding to integrin beta-1 (ITB1) and the receptor of activated protein kinase C | Complement activation, lectin pathway, fibrinolysis, and regulation of angiogenesis |
| Caldesmon | Actin- and myosin-binding protein | Cellular component movement, muscle contraction |
| Zyxin | Adhesion plaque protein. Binds alpha-actinin and the CRP prot | Cell adhesion |
| Desmin | Class-III intermediate filaments found in muscle cells | Cytoskeleton organization, muscle filament sliding |
| Vimentin | Vimentins are class-III intermediate filaments found in various nonepithelial cells, especially mesenchymal c | Intermediate filament organization |
| Macrophage-capping protein | Calcium-sensitive protein which reversibly blocks the barbed ends of actin filaments but does not sever preformed actin filaments. May play an important role in macrophage function. | Barbed-end actin filament capping, cell projection assembly |
| F-actin-capping protein subunit alpha-1 | F-actin-capping proteins bind in a Ca2+-independent manner to the fast growing ends of actin filaments | Actin cytoskeleton organization, actin filament capping, cellular component movement |
|
| ||
| Other proteins | ||
| SH3 domain-binding glutamic acid-rich-like protein | SH3/SH2 adaptor activity | SH3-binding |
| Ran-specific GTPase-activating protein | Inhibits GTP exchange on Ran | Positive regulation of GTPase activity |
| Lymphoid-restricted membrane protein | Vesicle fusion | Vesicle targeting |
| Chloride intracellular channel protein 1 | Can be inserted into membranes and form chloride ion channels. | Positive regulation of osteoblast differentiation |
| Enoyl-CoA hydratase | Straight-chain enoyl-CoA thioesters from C4 up to at least C16 | Fatty acid metabolism |
| Alpha-internexin | Class-IV neuronal intermediate filament | Differentiation, |
| Fatty acid-binding protein | High specificity for fatty acids. Highest affinity for C18 chain length. | Transport |
Figure 6Classification of identified proteins based on their molecular function and their involvement in biological processes. Pie chart representing the distribution of the 61 identified proteins based on their molecular function and biological processes. Assignments were made on the basis of information from PANTHER analysis (http://www.pantherdb.org/) as well as NCBI (http://www.ncbi.nlm.nih.gov/pubmed) and Swiss-Prot/TrEMBL annotations (http://www.expasy.org/).
Figure 7WB validation of the selected proteins identified by MALDI-TOF/TOF analysis. Western blot analysis was used for validation of proteomic results. Conventional 12% SDS gels were run with whole cell extracts. (a) Three lanes for SHED, DPSCs, and NDP-MSC are shown for each antibody. Galectin-1, DJ-1, UCHL-1, and HNRNPH1 antibodies were used for validation of expressions of the identified proteins. GAPDH was used for the normalization of each protein sample. (b) Relative protein intensities of bands were measured by Quantity One 1D analysis software (Bio-Rad). Each WB was repeated for three times. (c) Representative images of protein spots selected for WB analysis (protein identities corresponding to SSP numbers can be found in Table 2). (d) Comparative intensity graphs of selected protein spots generated by PDQuest Advance software (Bio-Rad).